# Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome

> **NCT07320612** · PHASE1 · COMPLETED · sponsor: **University of Child Health Sciences and Children's Hospital, Lahore** · enrollment: 160 (actual)

## Conditions studied

- Nephrotic Syndrome

## Interventions

- **DRUG:** Azithromycin and steroids
- **DRUG:** steroids

## Key facts

- **NCT ID:** NCT07320612
- **Lead sponsor:** University of Child Health Sciences and Children's Hospital, Lahore
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-03-08
- **Primary completion:** 2025-08-08
- **Final completion:** 2025-10-08
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07320612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07320612, "Efficacy And Safety Of Azithromycin To Achieve Remissionin In Children With Steroid Sensitive Nephrotic Syndrome". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07320612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*